• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用XpresHAn技术生产的透明质酸填充剂进行鼻唇沟矫正后,恢复社交活动所需的最短恢复时间。

Minimal recovery time needed to return to social engagement following nasolabial fold correction with hyaluronic acid fillers produced with XpresHAn technology.

作者信息

Swift Arthur, von Grote Erika, Jonas Brandie, Nogueira Alessandra

机构信息

Arthur Swift Research Inc., Montreal, QC, Canada.

Medical Affairs, Galderma Laboratories, L.P., Fort Worth, TX, USA.

出版信息

Clin Cosmet Investig Dermatol. 2017 Jun 14;10:229-238. doi: 10.2147/CCID.S138155. eCollection 2017.

DOI:10.2147/CCID.S138155
PMID:28652795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5476436/
Abstract

INTRODUCTION

The appeal of hyaluronic acid fillers for facial soft tissue augmentation is attributable to both an immediate aesthetic effect and relatively short recovery time. Although recovery time is an important posttreatment variable, as it impacts comfort with appearance and perceived treatment benefit, it is not routinely evaluated. Natural-looking aesthetic outcomes are also a primary concern for many patients.

MATERIALS AND METHODS

A single-center, noncomparative study evaluated the time (in hours) until subjects return to social engagement (RtSE) following correction of moderate and severe nasolabial folds (NLFs) with R (Restylane Refyne) and R (Restylane Defyne), respectively. Twenty subjects (aged 35-57 years) who received bilateral NLF correction documented their RtSE and injection-related events posttreatment. Treatment efficacy was evaluated by improvements in Wrinkle Severity Rating Scale (WSRS) and subject satisfaction questionnaire at days 14 and 30, and by Global Aesthetic Improvement Scale (GAIS) at day 30. Safety was evaluated by injection-related events and treatment-emergent adverse events.

RESULTS

Fifty percent of subjects reported RtSE within 2 hours posttreatment. WSRS for the R group improved significantly from baseline at day 14 (-1.45±0.42) and day 30 (-1.68±0.46) (<0.001), respectively. WSRS for the R group improved significantly from baseline at day 14 (-2.22±0.44) and day 30 (-2.50±0.50) (<0.004), respectively. All GAIS improvements were clinically significant at day 30. The majority of injection-related events were mild or moderate. Two subjects experienced 3 related treatment-emergent adverse events; 1 R subject experienced severe bruising, and 1 R subject experienced severe erythema and mild telangiectasia. Subject satisfaction was high regarding aesthetic outcomes and natural-looking results.

CONCLUSION

Optimal correction of moderate NLFs with R and severe NLFs with R involved minimal time to RtSE for most subjects. Treatments that significantly improved WSRS and GAIS, were generally well-tolerated, and provided natural-looking aesthetic outcomes.

摘要

引言

透明质酸填充剂用于面部软组织填充的吸引力既在于即时的美学效果,也在于相对较短的恢复时间。尽管恢复时间是治疗后的一个重要变量,因为它会影响外观舒适度和感知到的治疗益处,但并未常规进行评估。自然美观的美学效果也是许多患者的主要关注点。

材料与方法

一项单中心、非对照研究评估了分别使用瑞蓝丽瑅(Restylane Refyne)和瑞蓝唯瑅(Restylane Defyne)矫正中度和重度鼻唇沟(NLF)后受试者恢复社交活动(RtSE)所需的时间(以小时为单位)。20名年龄在35至57岁之间接受双侧鼻唇沟矫正的受试者记录了他们治疗后的RtSE及与注射相关的事件。在第14天和第30天通过皱纹严重程度评定量表(WSRS)和受试者满意度问卷评估治疗效果,在第30天通过整体美学改善量表(GAIS)评估。通过与注射相关的事件和治疗中出现的不良事件评估安全性。

结果

50%的受试者在治疗后2小时内报告恢复社交活动。瑞蓝丽瑅组的WSRS在第14天(-1.45±0.42)和第30天(-1.68±0.46)分别从基线显著改善(<0.001)。瑞蓝唯瑅组的WSRS在第14天(-2.22±0.44)和第30天(-2.50±0.50)分别从基线显著改善(<0.004)。在第30天所有GAIS改善均具有临床意义。大多数与注射相关的事件为轻度或中度。两名受试者经历了3次与治疗相关的不良事件;1名瑞蓝丽瑅受试者出现严重瘀伤,1名瑞蓝唯瑅受试者出现严重红斑和轻度毛细血管扩张。受试者对美学效果和自然外观结果的满意度较高。

结论

对于大多数受试者,使用瑞蓝丽瑅矫正中度鼻唇沟和使用瑞蓝唯瑅矫正重度鼻唇沟能使恢复社交活动的时间最短。这些治疗能显著改善WSRS和GAIS,通常耐受性良好,并能提供自然美观的美学效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d5/5476436/554fd8e019a9/ccid-10-229Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d5/5476436/d0b2e81e2128/ccid-10-229Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d5/5476436/7dd97ec36a03/ccid-10-229Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d5/5476436/6f26eba5d319/ccid-10-229Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d5/5476436/0c13c2348725/ccid-10-229Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d5/5476436/3ed805111f22/ccid-10-229Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d5/5476436/554fd8e019a9/ccid-10-229Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d5/5476436/d0b2e81e2128/ccid-10-229Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d5/5476436/7dd97ec36a03/ccid-10-229Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d5/5476436/6f26eba5d319/ccid-10-229Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d5/5476436/0c13c2348725/ccid-10-229Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d5/5476436/3ed805111f22/ccid-10-229Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d5/5476436/554fd8e019a9/ccid-10-229Fig6.jpg

相似文献

1
Minimal recovery time needed to return to social engagement following nasolabial fold correction with hyaluronic acid fillers produced with XpresHAn technology.采用XpresHAn技术生产的透明质酸填充剂进行鼻唇沟矫正后,恢复社交活动所需的最短恢复时间。
Clin Cosmet Investig Dermatol. 2017 Jun 14;10:229-238. doi: 10.2147/CCID.S138155. eCollection 2017.
2
Efficacy and safety of two hyaluronic acid fillers with different injection depths for the correction of moderate-to-severe nasolabial folds: A 52-week, prospective, randomized, double-blinded study in a Chinese population.两种不同注射层次透明质酸填充剂矫正中重度鼻唇沟的疗效和安全性:一项在中国人群中进行的为期 52 周、前瞻性、随机、双盲研究。
J Cosmet Dermatol. 2022 Mar;21(3):940-948. doi: 10.1111/jocd.14744. Epub 2022 Jan 12.
3
A multi-center comparative efficacy and safety study of two different hyaluronic acid fillers for treatment of nasolabial folds in a Chinese population.一项多中心、比较两种不同透明质酸填充剂治疗中国人群鼻唇沟皱纹的疗效和安全性的研究。
J Cosmet Dermatol. 2019 Jun;18(3):755-761. doi: 10.1111/jocd.12916. Epub 2019 May 10.
4
A 52-week follow-up, multi-center, randomized, double-blinded comparison of efficacy and safety of two hyaluronic acid fillers for the treatment of moderate-to-severe nasolabial folds in Chinese population.一项为期 52 周、多中心、随机、双盲的比较两种透明质酸填充剂治疗中国人群中中重度鼻唇沟的疗效和安全性的研究。
J Dermatolog Treat. 2024 Dec;35(1):2378165. doi: 10.1080/09546634.2024.2378165. Epub 2024 Jul 14.
5
Dynamics of hyaluronic acid fillers formulated to maintain natural facial expression.维持自然面部表情的透明质酸填充剂的动力学。
J Cosmet Dermatol. 2019 Jun;18(3):738-746. doi: 10.1111/jocd.12961. Epub 2019 Apr 29.
6
Safety and effectiveness of small and large gel-particle hyaluronic acid in the correction of perioral wrinkles.大小不同的凝胶颗粒透明质酸用于改善口周皱纹的安全性和有效性
J Drugs Dermatol. 2011 Sep;10(9):982-7.
7
Clinical comparison of two hyaluronic acid-derived fillers in the treatment of nasolabial folds: Mesoglow® and IAL System®.两种透明质酸衍生填充剂治疗鼻唇沟的临床比较:Mesoglow® 和 IAL System®。
Int J Dermatol. 2012 May;51(5):601-8. doi: 10.1111/j.1365-4632.2011.05347.x.
8
A Single-Center, Randomized, Double-Blind Clinical Trial to Compare the Efficacy and Safety of a New Monophasic Hyaluronic Acid Filler and Biphasic Filler in Correcting Nasolabial Fold.一项单中心、随机、双盲临床试验,旨在比较新型单相透明质酸填充剂和双相填充剂在纠正鼻唇沟中的疗效和安全性。
Aesthetic Plast Surg. 2021 Dec;45(6):2902-2908. doi: 10.1007/s00266-021-02252-0. Epub 2021 Apr 13.
9
A randomized, multicenter study on a flexible hyaluronic acid filler in treatment of moderate-to-severe nasolabial folds in a Chinese population.一项在中国人群中评估用于治疗中重度鼻唇沟的一款新型、柔软、单相透明质酸填充剂的随机、多中心研究。
J Cosmet Dermatol. 2022 Oct;21(10):4288-4293. doi: 10.1111/jocd.14914. Epub 2022 Jun 1.
10
The Efficacy and Safety of Lidocaine-Containing Hyaluronic Acid Dermal Filler for Treatment of Nasolabial Folds: A Multicenter, Randomized Clinical Study.含利多卡因的透明质酸真皮填充剂治疗鼻唇沟的疗效和安全性:一项多中心随机临床研究
Aesthetic Plast Surg. 2015 Dec;39(6):953-62. doi: 10.1007/s00266-015-0571-z. Epub 2015 Oct 22.

引用本文的文献

1
"I Want It to Look Natural": Development and Validation of the FACE-Q Aesthetics Natural Module.“我希望它看起来自然”:FACE-Q 美学自然模块的开发和验证。
Aesthet Surg J. 2024 Jun 14;44(7):733-743. doi: 10.1093/asj/sjad374.

本文引用的文献

1
A 12-Month Follow-up, Randomized Comparison of Effectiveness and Safety of Two Hyaluronic Acid Fillers for Treatment of Severe Nasolabial Folds.两种透明质酸填充剂治疗重度鼻唇沟的有效性和安全性的12个月随访随机对照研究
Dermatol Surg. 2017 Mar;43(3):389-395. doi: 10.1097/DSS.0000000000001031.
2
An 18-Month Follow-up, Randomized Comparison of Effectiveness and Safety of Two Hyaluronic Acid Fillers for Treatment of Moderate Nasolabial Folds.两种透明质酸填充剂治疗中度鼻唇沟的有效性和安全性的18个月随访随机对照比较
Dermatol Surg. 2017 Jan;43(1):58-65. doi: 10.1097/DSS.0000000000000923.
3
Effect of Different Crosslinking Technologies on Hyaluronic Acid Behavior: A Visual and Microscopic Study of Seven Hyaluronic Acid Gels.
不同交联技术对透明质酸性能的影响:七种透明质酸凝胶的视觉和微观研究
J Drugs Dermatol. 2016 May 1;15(5):600-6.
4
Key importance of compression properties in the biophysical characteristics of hyaluronic acid soft-tissue fillers.压缩特性在透明质酸软组织填充剂生物物理特性中的关键重要性。
J Mech Behav Biomed Mater. 2016 Aug;61:290-298. doi: 10.1016/j.jmbbm.2016.04.001. Epub 2016 Apr 8.
5
Dermal fillers in aesthetics: an overview of adverse events and treatment approaches.美容领域中的真皮填充剂:不良事件及治疗方法概述
Plast Surg Nurs. 2015 Jan-Mar;35(1):13-32. doi: 10.1097/PSN.0000000000000087.
6
Facial dynamics and emotional expressions in facial aging treatments.面部衰老治疗中的面部动态与情感表达
J Cosmet Dermatol. 2015 Mar;14(1):9-21. doi: 10.1111/jocd.12128. Epub 2015 Jan 24.
7
The Emervel French survey: a prospective real-practice descriptive study of 1,822 patients treated for facial rejuvenation with a new hyaluronic acid filler.Emervel法国调查:一项对1822例使用新型透明质酸填充剂进行面部年轻化治疗的患者的前瞻性实际应用描述性研究。
J Drugs Dermatol. 2013 May;12(5):e88-93.
8
A complete range of hyaluronic acid filler with distinctive physical properties specifically designed for optimal tissue adaptations.全系列透明质酸填充剂,具有独特物理特性,专为实现最佳组织适应性而设计。
J Drugs Dermatol. 2012 Jan;11(1 Suppl):s5-8.
9
The science and art of dermal fillers for soft-tissue augmentation.用于软组织填充的真皮填充剂的科学与艺术。
J Drugs Dermatol. 2009 Apr;8(4):335-50.
10
Comparative physical properties of hyaluronic acid dermal fillers.透明质酸真皮填充剂的比较物理特性。
Dermatol Surg. 2009 Feb;35 Suppl 1:302-12. doi: 10.1111/j.1524-4725.2008.01046.x.